{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/","result":{"pageContext":{"chapter":{"id":"6937cde7-2e91-5c9f-943e-a3772fdf8fff","slug":"symptomatic-hiv-infection","fullItemName":"Symptomatic HIV infection","depth":2,"htmlHeader":"<!-- begin field c1afae51-1351-452d-8317-d5b9b67824f1 --><h2>HIV diagnosis in people with symptoms</h2><!-- end field c1afae51-1351-452d-8317-d5b9b67824f1 -->","summary":"","htmlStringContent":"<!-- begin item 2549f5e0-587a-4f60-99be-612b6a9044f0 --><!-- end item 2549f5e0-587a-4f60-99be-612b6a9044f0 -->","topic":{"id":"6c2470d2-9bde-5a16-91a3-b5ed74ce2d2b","topicId":"23723770-8df0-4d05-aa4f-806db67f71df","topicName":"HIV infection and AIDS","slug":"hiv-infection-aids","lastRevised":"Last revised in July 2020","chapters":[{"id":"a83635cf-fad1-569e-8fec-1e53dd8ae096","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"21903de2-55a7-5de1-8f40-7d516cf2a7ba","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"34d5dabb-0626-5dfe-9e0a-07e7dac0ec58","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"996367e5-1657-59c5-9c56-45a1e1013995","slug":"changes","fullItemName":"Changes"},{"id":"e5a3550d-1cdf-573d-b498-dc61010e00ab","slug":"update","fullItemName":"Update"}]},{"id":"e6ed5291-d099-5df0-8884-8a42f12be67c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"da045857-e127-5b13-806b-efd61a584eed","slug":"goals","fullItemName":"Goals"},{"id":"f469da13-a03c-5ee1-94e5-b8eafe0a4710","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c9fb3313-7788-5815-b332-9c471eca306c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"63177a9d-218c-57dc-b3b2-7ed72c934d64","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cee63c61-94d3-58f8-baf1-490fff9ea45c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c8f3f309-15a8-577b-a923-a9df302e83dc","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5280ae8d-7f20-59e3-9659-6d5e8ee732d9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"77dcc0b6-d3f2-5853-af16-2b7fe5c92758","slug":"definitions","fullItemName":"Definitions"},{"id":"2ebcd00e-1208-5405-bf59-2bcb374d5cbf","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9568c950-bbaa-5f5f-aec3-01eb3d3f1cad","slug":"transmission-of-hiv-infection","fullItemName":"Transmission of HIV infection"},{"id":"d63a1c6b-b5d0-585d-b2bd-32d7585a1348","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"a37da596-8c70-54d6-a7c0-b3ff5e433932","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a8377091-e41a-5f81-ac03-60a09edc5331","slug":"complications","fullItemName":"Complications"}]},{"id":"86f39b6e-86fd-5704-81c5-1d7bc804e489","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6937cde7-2e91-5c9f-943e-a3772fdf8fff","slug":"symptomatic-hiv-infection","fullItemName":"Symptomatic HIV infection"},{"id":"bb429eff-4661-5c71-bccb-6c98e9738ee7","slug":"asymptomatic-hiv-infection","fullItemName":"Asymptomatic HIV infection"}]},{"id":"34037594-c7af-59e7-b51e-d4252ee167e2","fullItemName":"Management","slug":"management","subChapters":[{"id":"52deca6b-97b2-52f6-8f9b-734f8717e443","slug":"new-hiv-diagnosis","fullItemName":"Scenario: New HIV diagnosis"},{"id":"10c2085e-ef4b-579a-994f-267109c1bfb5","slug":"acute-hiv-related-problems","fullItemName":"Scenario: Acute HIV-related problems"},{"id":"4c89980b-d988-5bb0-97eb-85427710fb28","slug":"established-hiv-infection","fullItemName":"Scenario: Established HIV infection"},{"id":"fbe0aece-9feb-59c8-8a0e-b822d115f38c","slug":"post-exposure-prophylaxis","fullItemName":"Scenario: Post-exposure prophylaxis"}]},{"id":"5e2f04ec-05b3-5cf1-a129-77b19bc1c3fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"b7b51785-6622-5495-ab3a-eaf744121195","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0d080358-7d15-5c10-9583-e229d17ecc83","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e3da2b1c-f5c2-51bc-a4af-783d017c48ed","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"275bacfc-149b-5bad-aeb5-3b04ee60f812","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e73775d9-24cb-5d49-86c5-7394e52ada27","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e580fed6-5846-5aef-9890-4b21946b4ffb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"72914ee0-80fc-59a4-8670-236701fce130","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"86f39b6e-86fd-5704-81c5-1d7bc804e489","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"410f4154-67a9-5fb0-adc4-8ad1b360d471","slug":"when-to-suspect-hiv-infection","fullItemName":"When to suspect HIV infection","depth":3,"htmlHeader":"<!-- begin field d9343b10-67fb-4ec2-a726-a75f0065c51b --><h3>When should I suspect HIV infection?</h3><!-- end field d9343b10-67fb-4ec2-a726-a75f0065c51b -->","summary":null,"htmlStringContent":"<!-- begin item 1f7aa7fb-820a-4376-a14f-a75f0065c53d --><!-- begin field 1ced95c1-844a-4619-ace5-a75f0065c51b --><ul><li><strong>Consider the possibility of HIV infection in a person presenting with one or more of the following</strong><strong>:</strong><ul><li>Common symptoms or infections that are unusually severe, prolonged, recurrent, or unexplained.</li><li>Conditions related to immunosuppression, such as oral candidiasis or shingles.</li><li>Glandular fever-like illness.<ul><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/\">Glandular fever (infectious mononucleosis)</a>.</li></ul></li><li>Lymphadenopathy of unknown origin.</li><li>Pyrexia of unknown origin.</li><li>Weight loss of more than 10 kg.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/background-information/risk-factors/\">Risk factors</a> for HIV, such as living in, working in, or coming from a high prevalence area; sex between men; and injecting drug use.</li></ul></li><li><strong>Be aware that infants most often present with</strong><strong>:</strong><ul><li>Failure to thrive, <em>and/or</em></li><li>Pneumocystis pneumonia, <em>or</em></li><li>Cytomegalovirus disease, <em>or</em></li><li>HIV encephalopathy.</li></ul></li><li><strong>After the first year of life, consider HIV infection in children presenting with:</strong><ul><li>Recurrent infections such as upper respiratory tract infections.</li><li>Severe presentations of common childhood infections.</li><li>Chronic diarrhoea.</li><li>Herpes zoster.</li><li>Severe pneumonia.</li><li>Tuberculosis.</li><li>Lymphadenopathy.</li><li>Any <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/management/established-hiv-infection/#aids-defining-conditions\">AIDS-defining condition</a>.</li></ul></li><li><strong>For further information on primary HIV infection and conditions associated with establishedÂ HIV infection see the sections on:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#primary-hiv-infection\">Primary HIV infection</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#longstanding-hiv-infection\">Longstanding HIV infection</a>.</li></ul></li></ul><!-- end field 1ced95c1-844a-4619-ace5-a75f0065c51b --><!-- end item 1f7aa7fb-820a-4376-a14f-a75f0065c53d -->","subChapters":[]},{"id":"7fed9d73-782d-576f-9b7a-110e61e65152","slug":"primary-hiv-infection","fullItemName":"Primary HIV infection","depth":3,"htmlHeader":"<!-- begin field 2a43f055-6028-4db4-a40f-abf400c64ca0 --><h3>Primary HIV infection</h3><!-- end field 2a43f055-6028-4db4-a40f-abf400c64ca0 -->","summary":null,"htmlStringContent":"<!-- begin item 5ba6a99f-1a2f-432a-ac1d-abf400c64c3b --><!-- begin field 04082e07-fdb6-4cd1-abde-abf400c64ca0 --><ul><li><strong>Primary HIV infection or HIV seroconversion illness </strong>occurs in the first few weeks following infection with HIV (usually between 10 days and 6 weeks) and can be mild or severe.</li><li><strong>Clinical features associated with primary HIV infection </strong>develop in over 60% of people, can be non-specific, and include:<ul><li>Fever, sore throat, maculopapular rash, malaise, lethargy, arthralgia, myalgia, lymphadenopathy, and oral, genital or perianal ulcers.</li><li>Less commonly, headache, meningitis, cranial nerve palsies, diarrhoea, and weight loss.</li></ul></li></ul><!-- end field 04082e07-fdb6-4cd1-abde-abf400c64ca0 --><!-- end item 5ba6a99f-1a2f-432a-ac1d-abf400c64c3b -->","subChapters":[]},{"id":"49133b93-a8cc-5ba1-8ec9-a646d7c684f9","slug":"longstanding-hiv-infection","fullItemName":"Longstanding HIV infection","depth":3,"htmlHeader":"<!-- begin field 9fccf92c-d396-4a2d-a6d3-a75f006a36c3 --><h3>Longstanding HIV infection</h3><!-- end field 9fccf92c-d396-4a2d-a6d3-a75f006a36c3 -->","summary":null,"htmlStringContent":"<!-- begin item d1ee8303-68ec-49dd-bed4-a75f006a3716 --><!-- begin field f002756c-2760-4353-980e-a75f006a36c3 --><p><strong>Conditions associated with longstanding HIV infection </strong>can be subtle and people may remain well for some time before developing another condition. Consider HIV if a person has had more than one of the following in the past 3 years, or has had conditions that are severe or resistant to treatment.</p><h4>Constitutional symptoms</h4><ul><li>Constitutional symptoms may be due to HIV infection itself, a related opportunistic infection (such as tuberculosis), or malignancy (such as lymphoma), and include:<ul><li>Flu-like symptoms.</li><li>Fever.</li><li>Weight loss.</li><li>Sweats.</li><li>Lymphadenopathy.</li></ul></li></ul><p><strong>Respiratory conditions</strong></p><ul><li>Opportunistic respiratory infections such as pneumocystis pneumonia (PCP), tuberculosis, bacterial lower respiratory tract infections; and occasionally Kaposi's sarcoma or lymphomas can result in symptoms including cough, sweats, breathlessness, and weight loss.<ul><li><strong>PCP</strong> <strong>is a life-threatening condition</strong> that can be difficult to identify at onset and is typically insidious over several weeks.<ul><li>Symptoms include fever (in most but not all people), persistent dry cough of a few weeksâ duration, increasing breathlessness, decreasing exercise tolerance, chest discomfort, and difficulty in taking a full breath.</li><li>Signs include fine crackles (although the chest may be clear, especially in early infection) and a drop in oxygen saturation on exertion.</li><li>PCP can be fatal if diagnosed late.</li></ul></li><li><strong>Tuberculosis (TB) and atypical mycobacterial disease</strong><ul><li>TB is a common presenting condition in HIV. Atypical mycobacterial disease (such as <em>Mycobacterium avium intracellulare</em>) is less common and is associated with advanced HIV infection.</li><li>Symptoms may include fever, night sweats, weight loss, fatigue, diarrhoea, and abdominal pain.</li></ul></li></ul></li><li>For further information, see the CKSÂ topics on <a class=\"topic-reference external-reference\" href=\"/topics/chest-infections-adult/\">Chest infections - adult</a>, <a class=\"topic-reference external-reference\" href=\"/topics/cough/\">Cough</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a>.</li></ul><h4>Neurological and visual conditions</h4><ul><li><strong>HIV infection is associated with many neurological and visual problems including</strong><strong>:</strong><ul><li><strong>Cryptococcal meningitis </strong>â may present as subacute meningitis with headache and fever, acute confusional state, or cranial nerve palsies.<ul><li>Typical symptoms and signs of meningism may be absent.</li></ul></li><li><strong>Cerebral toxoplasmosis</strong> â occurs owing to reactivation of previous toxoplasmosis infection.<ul><li>May present with confusion, headache, personality change, fever, fits, and focal neurological signs.</li></ul></li><li><strong>Cerebral lymphoma</strong> (in advanced HIV disease).<ul><li>May present with confusion, lethargy, personality change, headache, fever, fits, and focal neurological signs.</li></ul></li><li><strong>Cytomegalovirus (CMV) retinitis</strong> occurs owing to reactivation of previously acquired infection and can lead to loss of vision.<ul><li>Prognosis improves with earlier diagnosis.</li><li>Symptoms include floaters (due to inflammatory cells in the vitreous), reduced vision, flashing lights, and scotomas.</li></ul></li></ul></li></ul><h4>Cancers</h4><ul><li><strong>HIV infection is associated with increased risk of malignancy including:</strong><ul><li><strong>Lymphoma</strong><ul><li>Lymphoma can present with weight loss, fevers, night sweats, lymphadenopathy, and abdominal masses (lymph nodes, hepatomegaly, or splenomegaly).</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/haematological-cancers-recognition-referral/\">Haematological cancers - recognition and referral</a>.</li></ul></li><li><strong>Kaposi's sarcoma</strong><ul><li>Kaposi's sarcoma is the most common tumour in people with HIV infection and typically presents with dark purple or brown intradermal skin lesions that look like bruises but feel firmer.</li><li>Tumours may occur anywhere on the skin or oropharynx â infiltration of the lungs or gut is rare but can be life threatening.</li></ul></li><li><strong>Cervical cancer</strong><ul><li>Cervical cancer can present with vaginal bleeding or discharge. For further information, see the CKSÂ on <a class=\"topic-reference external-reference\" href=\"/topics/cervical-cancer-hpv/\">Cervical cancer and HPV</a>.</li><li>Abnormal cervical cytology may be a marker for underlying HIV infection.</li></ul></li></ul></li></ul><h4>Skin conditions </h4><ul><li>In addition to Kaposiâs sarcoma, HIV infection is associated with many common skin conditions. These are often unusually severe, recurrent, or resistant to treatment, and include:<ul><li><strong>Fungal skin and nail infections</strong><ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-body-groin/\">Fungal skin infection - body and groin</a>, <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-foot/\">Fungal skin infection - foot</a>, <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-scalp/\">Fungal skin infection - scalp</a>, <a class=\"topic-reference external-reference\" href=\"/topics/fungal-nail-infection/\">Fungal nail infection</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/pityriasis-versicolor/\">Pityriasis versicolor</a>.</li></ul></li><li><strong>Viral infections </strong>such as herpes simplex (especially if the ulcers are unusually large or persistent), molluscum contagiosum, shingles (especially if more than one dermatome is affected), and warts.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-genital/\">Herpes simplex - genital</a>, <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-ocular/\">Herpes simplex - ocular</a>, <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-oral/\">Herpes simplex - oral</a>, <a class=\"topic-reference external-reference\" href=\"/topics/molluscum-contagiosum/\">Molluscum contagiosum</a>, <a class=\"topic-reference external-reference\" href=\"/topics/shingles/\">Shingles</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/warts-verrucae/\">Warts and verrucae</a>.</li></ul></li><li><strong>Bacterial infections </strong>such as impetigo and folliculitis.<ul><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/impetigo/\">Impetigo</a>.</li></ul></li><li><strong>Seborrhoeic dermatitis and psoriasis</strong><ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/psoriasis/\">Psoriasis</a>.</li></ul></li></ul></li></ul><h4>Oral conditions</h4><ul><li><strong>HIV infection is associated with: </strong><ul><li><strong>Oral candidiasis</strong><ul><li>Typically presents with thick white plaques covering the buccal mucosa that can be scraped off. Soreness of the mouth or pain on swallowing (odynophagia) may also be present.</li><li>For further information, see the CKSÂ topic on <a class=\"topic-reference external-reference\" href=\"/topics/candida-oral/\">Candida - oral</a>.</li></ul></li><li><strong>Aphthous ulcers</strong><ul><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/aphthous-ulcer/\">Aphthous ulcer</a>.</li></ul></li><li><strong>Oral hairy leukoplakia</strong><ul><li>Typically presents as asymptomatic corrugated whitish, hairy patches on the side of the tongue that cannot be scraped off (in contrast to oral candidiasis) and is pathognomic of immunosuppression.</li></ul></li><li><strong>Kaposi's sarcoma</strong><ul><li>Most often affects the hard and soft palate, gingiva, and dorsal tongue with plaques or tumours of variable colour from non-pigmented to brownish-red or purple.</li></ul></li><li><strong>Gingivitis</strong><ul><li>Causes swelling and erythema of the gum margins that are usually painful and bleed on tooth brushing or flossing.</li><li>See the CKSÂ topic on <a class=\"topic-reference external-reference\" href=\"/topics/gingivitis-periodontitis/\">Gingivitis and periodontitis</a> for further information.</li></ul></li><li><strong>Dental abscess</strong><ul><li>Typically presents with rapid onset of severe dental pain and may be associated with an unpleasant taste in the mouth, fever, and malaise.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dental-abscess/\">Dental abscess</a>.</li></ul></li></ul></li></ul><h4>Gastrointestinal conditions</h4><ul><li><strong>HIV infection is associated with: </strong><ul><li><strong>Oesophageal candidiasis</strong><ul><li>Symptoms include retrosternal pain or dysphagia. Oral candidiasis is also likely to be present.</li></ul></li><li><strong>Diarrhoea</strong><ul><li>Diarrhoea is very common and may be persistent and mild or acute and severe.</li><li>Infection due to bacteria, protozoa (such as <em>Cryptosporidium</em>), mycobacteria, or viruses; malignancy (such as non-Hodgkin's lymphoma or Kaposi's sarcoma), or the direct effects of HIV can all result in diarrhoea.</li><li>Often no specific causative organism is identified.</li></ul></li><li><strong>HepatitisÂ B and hepatitisÂ C infection</strong><ul><li>Co-infection with hepatitisÂ B orÂ C is common and increases the risk of cirrhosis and hepatocellular carcinoma.</li><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>.</li></ul></li></ul></li></ul><h4>Genital conditions</h4><ul><li>Consider HIV infection in anyone presenting with severe or difficult-to-treat genital candida, genital herpes, or genital warts.<ul><li>For further information, see the CKSÂ topics on <a class=\"topic-reference external-reference\" href=\"/topics/candida-female-genital/\">Candida - female genital</a>, <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-genital/\">Herpes simplex - genital</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/warts-anogenital/\">Warts - anogenital</a>.</li></ul></li></ul><h4>Haematological conditions</h4><ul><li>Consider HIV infection in anyone with unexplained abnormalities on full blood count such as neutropenia, anaemia, thrombocytopenia, or other blood dyscrasias.</li></ul><!-- end field f002756c-2760-4353-980e-a75f006a36c3 --><!-- end item d1ee8303-68ec-49dd-bed4-a75f006a3716 -->","subChapters":[]},{"id":"f9a89b50-ff64-57c4-a586-742ca6719187","slug":"how-should-i-assess-a-person-with-suspected-hiv-infection","fullItemName":"How should I assess a person with suspected HIV infection?","depth":3,"htmlHeader":"<!-- begin field 4c50f489-a41a-45aa-9bcf-a75f0065f633 --><h3>How should I assess a person with suspected HIV infection?</h3><!-- end field 4c50f489-a41a-45aa-9bcf-a75f0065f633 -->","summary":null,"htmlStringContent":"<!-- begin item e2e8e61f-8536-42c1-82d0-a75f0065f61c --><!-- begin field 3a09b502-ed91-45e1-8e2f-a75f0065f633 --><ul><li><strong>Take a history, asking about</strong><strong>:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#when-to-suspect-hiv-infection\">Symptoms</a> that may be HIV-related such as fever, weight loss, sweats, diarrhoea, lymphadenopathy, skin rashes, cough, oral candida, and aphthous ulcers.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/background-information/risk-factors/\">risk factors</a>.</li><li>Past medical history, including hospital admissions as these may be related to HIV infection.</li></ul></li><li><strong>Examine the person for</strong><strong>:</strong><ul><li>Rash â in particular a generalized maculopapular rash.</li><li>Lymphadenopathy, particularly in extra-inguinal sites.</li><li>Signs of immunocompromise such as oral candidiasis.</li><li>Signs of <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#when-to-suspect-hiv-infection\">HIV-related conditions</a><u>,</u> being alert for those that are serious or life threatening, such as:<ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#longstanding-hiv-infection\">Pneumocystis pneumonia</a>.</li><li>Tuberculosis â for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#longstanding-hiv-infection\">Cytomegalovirus (CMV) retinitis</a>.</li><li>Lymphoma â for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/haematological-cancers-recognition-referral/\">Haematological cancers - recognition and referral</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#longstanding-hiv-infection\">Kaposi's sarcoma</a>.</li></ul></li></ul></li><li><strong>Review the person's medical records for evidence of previous HIV-associated problems</strong><strong>.</strong></li></ul><!-- end field 3a09b502-ed91-45e1-8e2f-a75f0065f633 --><!-- end item e2e8e61f-8536-42c1-82d0-a75f0065f61c -->","subChapters":[]},{"id":"e5c8618f-d407-5c5f-b826-38b95d83d306","slug":"how-to-test-for-hiv","fullItemName":"How to test for HIV","depth":3,"htmlHeader":"<!-- begin field e35e98d8-c63e-4258-b8e3-a75f00660c0b --><h3>How should I test for HIV?</h3><!-- end field e35e98d8-c63e-4258-b8e3-a75f00660c0b -->","summary":null,"htmlStringContent":"<!-- begin item 377d30be-4599-471c-9bd9-a75f00660c8e --><!-- begin field c8570e39-25c1-42ad-b6b0-a75f00660c0b --><ul><li><strong>Check the persons understanding of HIV.</strong></li><li><strong>Decide with the person whether urgent assessment by a specialist is required and whether HIV testing should be carried out in primary care or elsewhere.</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/management/acute-hiv-related-problems/#who-should-i-admit\">Arrange admission</a> for urgent specialist assessment if there is concern about the possibility of a serious HIV-related condition such asÂ <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#longstanding-hiv-infection\">Pneumocystis pneumonia</a>.</li><li>If admission is not required, discuss the timing between testing and availability of the result, as this may alter some people's preferences as to where they are tested:<ul><li>Timing of test results varies depending on local laboratory facilities â some services may be able to provide results more rapidly if requested. For further information on specific tests, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/management/established-hiv-infection/#tests-to-monitor-hiv-infection\">Tests for HIV infection</a>.</li><li>Specialist services such as genito-urinary medicine (GUM) clinics usually provide results on the same day.</li><li>Some organizations, such as the Terence Higgins Trust (an HIV/AIDS charity) offer testing services with results available within the hour. Further information (including on online ordering of self-tests and postal test kits) is available on their <a href=\"http://www.tht.org.uk/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"92d56e66-97f0-47f2-97ed-abf800f24fc0\">website</a>.</li></ul></li><li>Consider referral to GUM for testing if the person has mental health problems or additional counselling needs as specialist input may be required.</li></ul></li><li><strong>Pre-test counselling should include discussion of</strong><strong>:</strong><ul><li><strong>The benefits of HIV testing:</strong><ul><li>If the test is negative, the person can be reassured and given advice on reducing the risk of HIV infection.</li><li>If the test is positive, effective treatment can help prevent HIV-related illness and ensure that infection is not transmitted to contacts or in pregnancy.</li></ul></li><li><strong>Details of how theÂ <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/diagnosis/symptomatic-hiv-infection/#giving-an-hiv-test-result\">result will be given</a>:</strong><ul><li>Check you have correct contact details, the preferred method of contact, and whether there may be any problems with leaving messages or talking.</li><li>If possible, arrange an appointment for the result to be given â negative results may be discussed by telephone.</li></ul></li><li><strong>The significance of the window period</strong> as a repeat test may be necessary.<ul><li>The window period is the time between becoming infected and antibodies appearing â HIV antibodies usually appear 4â6 weeks after infection but can take up to 12 weeks.</li></ul></li><li><strong>The importance of confidentiality</strong> and that the result will need to be recorded in medical records.</li></ul></li><li><strong>Ensure that informed consent has been given for the test</strong> â written consent is not required.</li><li><strong>If the person is at risk sexually and/or through injecting drug use:</strong><ul><li>Refer for further assessment (including screening for hepatitis and other sexually transmitted infections) and support to the local GUM clinic or substance misuse service.</li></ul></li></ul><!-- end field c8570e39-25c1-42ad-b6b0-a75f00660c0b --><!-- end item 377d30be-4599-471c-9bd9-a75f00660c8e -->","subChapters":[]},{"id":"5c132325-a5d5-5790-86a2-aadeeee5b6c2","slug":"giving-an-hiv-test-result","fullItemName":"Giving an HIV test result","depth":3,"htmlHeader":"<!-- begin field fb54eae7-9fc4-40b2-b823-a75f006624ed --><h3>How should I give the result of an HIV test?</h3><!-- end field fb54eae7-9fc4-40b2-b823-a75f006624ed -->","summary":null,"htmlStringContent":"<!-- begin item 8e244a88-4a47-472b-9544-a75f00662561 --><!-- begin field cb4ff1d0-59b0-44c3-bbc9-a75f006624ed --><ul><li><strong>If possible, give results in a face-to-face consultation.</strong></li><li><strong>If the test is negative</strong><strong>:</strong><ul><li>Consider if a further test is needed to cover the <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/management/established-hiv-infection/#tests-to-monitor-hiv-infection\">window period</a>Â â seek specialist advice from genito-urinary medicine (GUM) if unsure.</li><li>Reinforce advice about <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/management/established-hiv-infection/#sexual-reproductive-health\">minimizing risk</a> where appropriate.</li></ul></li><li><strong>If the test is positive:</strong><ul><li>The laboratory is likely to telephone the result through and ask for a repeat sample.</li><li>Emphasize the positive aspects â effective treatment can help prevent HIV-related illness and ensure that infection is not transmitted to contacts or in pregnancy.</li><li>Explain the referral process â for further information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hiv-infection-aids/management/new-hiv-diagnosis/\">New diagnosis of HIV</a>.</li><li>Discuss concerns and sources of support.</li><li>Arrange follow up within the next few days as the person is likely to have additional questions.</li></ul></li><li><strong>Non-attendance for positive results:</strong><ul><li>Follow the practice's usual recall process.</li><li>If recall is unsuccessful, seek advice from a local GUM or HIV clinic, as they will have experience in managing this.</li></ul></li></ul><!-- end field cb4ff1d0-59b0-44c3-bbc9-a75f006624ed --><!-- end item 8e244a88-4a47-472b-9544-a75f00662561 -->","subChapters":[]},{"id":"c525d24d-bf35-5d0d-9ef6-863d76c9577a","slug":"basis-for-recommendation-5be","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field dc0c222f-4eed-453b-af45-abf400c7845d --><h3>Basis for recommendation</h3><!-- end field dc0c222f-4eed-453b-af45-abf400c7845d -->","summary":null,"htmlStringContent":"<!-- begin item 5be5a85f-7d6a-447d-92d2-abf400c783dd --><!-- begin field 4c2bdb41-7788-4e00-89b5-abf400c7845d --><p>Recommendations on assessment of a person with suspected HIV are based on the clinical guidelines <em>UK guidelines for HIV testing 2008 </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BHIVA, 2008b</a>], <em>HIV in primary care. A practical guide for primary healthcare professionals in Europe</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">Matthews, 2016</a>], <em>British HIV Association/British Infection Association guidelines on the management of opportunistic infection in people living with HIV</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BHIVA, 2019b</a>],Â and <em>Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">CDC, 2019</a>];Â a statement from the British Association of Sexual Health and HIV (BASHH) and the UK Chief Medical Officers' Expert Advisory Group on AIDS (EAGA) <em>BASHH/EAGA statement on HIV window period</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BASHH, 2014</a>]; and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">Goldschmidt, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">Kirkham, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">Lebari, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BMJ Best Practice, 2020b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BMJ Best Practice, 2020a</a>].</p><h4>Constitutional symptoms</h4><ul><li>The UK National Guidelines for HIV testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BHIVA, 2008b</a>] recommend that people with glandular fever-like syndrome, pyrexia of unknown origin, weight loss, or lymphadenopathy of unknown cause should be offered an HIV test.</li><li>At the time of writing (July 2020), the British HIV Association (BHIVA) Guidelines Subcommittee, the British Association for Sexual Health and HIV (BASHH) Clinical Effectiveness Group, and the British Infection Association (BIA) Adult HIV Testing guidelines were in the process of being updated.</li></ul><h4>Haematological problems</h4><ul><li>The UK National Guidelines for HIV testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BHIVA, 2008b</a>] recommend that an HIV test is offered to people with unexplained neutropenia, anaemia, thrombocytopenia, or other blood dyscrasias.</li></ul><h4>HIV testing</h4><ul><li>HIV testing using 'fourth generation' tests are recommended in guidance from BHIVA, EAGA, and the Medical Foundation for HIV & Sexual Health (MEDFASH) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BHIVA, 2008b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BASHH, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">Matthews, 2016</a>].<ul><li>At the time of writing (July 2020) the BHIVA Guidelines Subcommittee, the BASHH Clinical Effectiveness Group, and the BIA Adult HIV Testing Guidelines (2020) were in the process of being updated.</li></ul></li><li>Fourth generation assays testing for HIV antibodies and p24 antigen in venous samples will detect the majority of people infected with HIV at 4 weeks after exposure [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">Matthews, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">NICE, 2016</a>].<ul><li>A negative result at 4 weeks post exposure is highly likely to exclude HIV infection â an additional HIV test at 8 weeks need only be considered following an exposure assessed as high risk for infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BASHH, 2014</a>].</li><li>The BASHH/EAGA statement on HIV window periodÂ states that people attending for HIV testing who identify a specific risk occurring less than 4 weeks previously, should not be made to wait before HIV testing â a fourth generation HIV test should be offered with repeat testing at 4 weeks from the time of last exposure.</li><li>Retesting at regular intervals is advised for those with ongoing risk of HIV [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BASHH, 2014</a>].</li><li>Testing for other sexually transmitted infections should be advised and people at risk of hepatitis B virus who are not immune should be immunized [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">BASHH, 2014</a>].</li></ul></li></ul><!-- end field 4c2bdb41-7788-4e00-89b5-abf400c7845d --><!-- end item 5be5a85f-7d6a-447d-92d2-abf400c783dd -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}